Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 10, 2014 13:00 ET | Source: Calithera Biosciences, Inc.

Calithera Presents Novel Pharmacodynamic Assay Data Confirming Glutaminase Inhibition in Tumor Biopsy Samples From Patients Treated With CB-839

SOUTH SAN FRANCISCO, Calif., Dec. 10, 2014 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on the development of novel cancer agents,...
December 09, 2014 09:00 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences Gains Exclusive, Worldwide License to Mars Symbioscience's Arginase Inhibitors

SOUTH SAN FRANCISCO, Calif., Dec. 9, 2014 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA) announced today the signing of an exclusive global license agreement with Mars...
December 08, 2014 12:00 ET | Source: Calithera Biosciences, Inc.

Calithera Presents Preclinical Study Findings for CB-839 at the 56th American Society of Hematology Annual Meeting

-Potential Biomarkers of Response to CB-839 Identified in Myeloma Cells -Synergy of CB-839 With Pomalidomide Demonstrated in Multiple Myeloma Models SOUTH SAN FRANCISCO, Calif., Dec. 8, 2014...
December 02, 2014 17:00 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences Appoints H. Ward Wolff to Board of Directors

SOUTH SAN FRANCISCO, Calif., Dec. 2, 2014 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
November 14, 2014 08:30 ET | Source: Calithera Biosciences, Inc.

Calithera Reports Financial Results for the Fiscal Quarter Ended September 30, 2014

SOUTH SAN FRANCISCO, Calif., Nov. 14, 2014 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
November 06, 2014 09:17 ET | Source: Calithera Biosciences, Inc.

Calithera Announces Multiple Abstracts Selected for Presentation at the 56th American Society of Hematology Annual Meeting

SOUTH SAN FRANCISCO, Calif., Nov. 6, 2014 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA) announced today that four preclinical abstracts highlighting the potential of CB-839, the...
October 02, 2014 08:00 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences, Inc. Announces Pricing of Initial Public Offering

SOUTH SAN FRANCISCO, Calif., Oct. 2, 2014 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company, today announced the pricing of its initial public...